Summary of Stock Information
Listing | Tokyo Stock Exchange Mothers |
Date of Listing | December 6, 2013 |
Code | 4588 |
Company Name | Oncolys BioPharma Inc. |
Number of shares outstanding | 9,225,300 (as of June 2016) |
Stock transaction unit | 100 shares |
Number of shareholders | 8,752 (as of June 2016) |
Fiscal Year | January 1 to December 31 |
General Meeting of Shareholders | Within 3 months of the relevant fiscal year end |
Transfer agent | Sumitomo Mitsui Trust Bank, Limited |
Name of major shareholders | Number of shares owned (shares) | Ownership (%) |
---|---|---|
ASTELLAS PHARMA INC | 727,200 | 7.88 |
WONIK CUBE CORP | 712,900 | 7.73 |
YASUO URATA | 320,700 | 3.48 |
DAIWA SECURITIES | 248,700 | 2.7 |
NVCC NO.6 INVESTMENT LIMITED PARTNERSHIP | 211,000 | 2.29 |
MATSUI SECURITIES | 146,400 | 1.59 |
JAPAN SECURITIES FINANCE | 144,900 | 1.57 |
BNY GCM CLIENT ACCOUNT JPRD AC ISG | 137,010 | 1.49 |
INDIVIDUAL | 120,100 | 1.3 |
MIZUHO SECURITIES ASIA LIMITED-CLIENT A/C 69250601 | 101,300 | 1.1 |